Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125276401 | 12527640 | 1 | I | 20160620 | 20160705 | 20160705 | EXP | GB-HERITAGE PHARMACEUTICALS-2016HTG00170 | HERITAGE | COOPER G, THOMPSON JP, VALE JA, EDDLESTON M, THOMAS SHL, COULSON JM. A REVIEW OF ENQUIRIES RECEIVED BY THE UK NATIONAL POISONS INFORMATION SERVICE (NPIS) FROM ENGLAND AND WALES INVOLVING CALCIUM CHANNEL BLOCKING DRUGS 2009-2013. CLIN TOXICOL. 2016;54(4):410 | 0.00 | Y | 0.00000 | 20160705 | OT | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125276401 | 12527640 | 1 | PS | NIFEDIPINE. | NIFEDIPINE | 1 | Unknown | 202644 | |||||||||||
| 125276401 | 12527640 | 2 | SS | UNSPECIFIED MEDICATIONS | UNSPECIFIED INGREDIENT | 1 | Unknown | 0 |
Indications of drugs used
| no results found |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125276401 | 12527640 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125276401 | 12527640 | Death | |
| 125276401 | 12527640 | Intentional overdose |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |